Tops & Flops Stocks
| Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cytomx Therapeutics Inc | -0.050% | 152.089% | 104.015% | 152.418% | 176.648% | -42.954% | - |
| Dare Bioscience Inc. | -1.030% | 3.214% | -36.900% | -68.207% | -2.365% | -74.425% | - |
| Deciphera Pharmaceuticals | - | -0.855% | 71.852% | 91.025% | 57.877% | -17.143% | - |
| Dermira Inc | -1.740% | - | - | - | - | - | - |
| Durect Corp. | -8.040% | - | - | - | - | - | - |
| Dynavax Technologies Corp | -0.500% | 1.925% | -2.251% | 9.403% | -15.558% | 34.711% | 87.058% |
| Eagle Pharmaceuticals Inc | 1.810% | 15.625% | -7.500% | -83.308% | -0.893% | -87.386% | -91.589% |
| Editas Medicine Inc | -12.240% | -3.916% | -24.346% | -46.446% | -50.255% | -83.288% | -79.183% |
| Egalet Corp | - | - | - | - | - | - | - |
| Eidos Therapeutics | 5.050% | - | - | - | - | - | - |
| Eledon Pharmaceuticals Inc. | -7.210% | 2.778% | 43.226% | -9.756% | 35.366% | -70.789% | -94.482% |
| Eli Lilly Corp. | -0.220% | -1.570% | 0.628% | 83.325% | 36.591% | 349.066% | 592.396% |
| Enanta Pharmaceuticals Inc. | -13.330% | 6.299% | -9.396% | -56.169% | 53.409% | -66.080% | -83.286% |
| Endocyte Inc. | - | - | - | - | - | - | - |
| Endo International | -16.670% | - | - | - | - | - | - |
| Epizyme Inc. | - | - | - | - | - | - | - |
| Esperion Therapeutis.Inc. | -11.230% | 2.351% | -32.017% | 53.734% | -34.007% | -89.645% | -95.809% |
| Evoke Pharma Inc. | -2.880% | -2.885% | -21.553% | -79.175% | -57.249% | -97.315% | -94.685% |
| Exact Sciences | -2.740% | 2.698% | -13.118% | -8.377% | -16.693% | -33.508% | -37.871% |
| Exelixis Inc. | -0.390% | -7.458% | -4.728% | 17.562% | -6.993% | -1.405% | 10.382% |
| EyeGate Pharmaceuticals Inc | 1.310% | - | - | - | - | - | - |
| EyePoint Pharmaceuticals Inc. | -3.080% | -31.254% | -42.967% | 82.119% | -49.790% | 33.478% | - |
| Fate Therapeutics Inc. | -6.250% | -6.708% | -44.064% | -30.055% | -3.009% | -94.524% | - |
| Fibrogen Inc. | -18.050% | 11.681% | -29.567% | -93.478% | 22.849% | -93.647% | - |
| Five Prime Therapeutics | - | - | - | - | - | - | - |